IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER

@article{Baum1983IMPROVEDSA,
  title={IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER},
  author={M. Baum and J. A. Dossett and J. Patterson and F. Smiddy and A. Wilson and D. Richards and D. Brinkley and K. Mcpherson and R. Rubens and B. Stoll and J. C. Lea and S. Ellis},
  journal={The Lancet},
  year={1983},
  volume={322}
}
Estimated Projection of US Cancer Incidence and Death to 2040
TLDR
The results estimate that leading cancer incidences and deaths in the US will be notably different in the year 2040 compared with current rankings. Expand
Adjuvant Systemic Therapy in Breast Cancer
TLDR
Systemic adjuvant therapy including endocrine therapy, chemotherapy, and HER2-targeted therapy are discussed including endocrinology, radiation, and chemotherapy for patients with early-stage breast cancer. Expand
Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide.
TLDR
The mortality for lung and breast cancer is higher in high- income countries than in middle-income countries; lung cancer mortality is lower in the latter because the tobacco epidemic is not yet widespread; due to these observed characteristics of lung cancer, primary prevention should still be a key factor to decrease lung cancer deaths. Expand
Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial
TLDR
Two years of adjuvant tamoxifen resulted in a sustained reduction in mortality in pre- and postmenopausal high-risk breast cancer patients with long-term follow-up data. Expand
Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
TLDR
It is revealed that sensitivity to chemotherapy depends on the levels of estrogen in breast cancer cells, and the role of estrogen-induced hypermethylation in enhanced sensitivity of these drugs in estrogen-exposed cells is understood. Expand
Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?
TLDR
Extended adjuvant therapy targeted to the estrogen receptor (ER) has significantly decreased mortality from breast cancer (BC) and the goal is to maintain patients for their natural lives by blocking cancer cell survival through precision medicine and further extended antihormone maintenance. Expand
Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975–2013
In recent decades, management of prostate and breast cancer patients has changed considerably. The purpose of our study is to interpret patterns of prostate and breast cancer incidence and mortalityExpand
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.
TLDR
Results suggest miR-29b-1/a has tumor suppressor activity in TAM-resistant cells and does not appear to play a role in mediating TAM resistance. Expand
Bayesian prediction of lung and breast cancer mortality among women in Spain (2014-2020).
TLDR
By 2020 the LC mortality rates may exceed those of BC for ages 55-74 years, possibly because of the prevalence of smoking among women, and the screening for and more effective treatment of BC. Expand
Treatment for Dementia: Learning from Breakthroughs for Other Conditions.
TLDR
This project analysed breakthroughs in the treatment of four selected conditions of ill health and seeks to identify potentially transferable lessons for the dementia context, focusing on political, economic, social, scientific and technological, and legal, regulatory and environmental factors. Expand
...
1
2
3
4
5
...

References

SHOWING 1-3 OF 3 REFERENCES
Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs.
  • M. Oliver
  • Medicine
  • The New England journal of medicine
  • 1982
TLDR
It has been assumed that the risks associated with drug treatment are low because they relate mostly to predictable minor side effects or idiosyncratic reactions, but when reactions include increased morbidity and mortality, a reappraisal is necessary. Expand
Statistics: the problem of examining accumulating data more than once.
A RECURRING decision that has to be made in planning a controlled clinical trial of a new treatment is the size of the patient sample necessary. In this decision, a major determinant is ethical, fo...
Regression Models and Life-Tables
The analysis of censored failure times is considered. It is assumed that on each individual arc available values of one or more explanatory variables. The hazard function (age-specific failure rate)Expand